93 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
and efficacy of repeat-administration of autologous MSC-NTF cells and was supported by a grant from the California Institute for Regenerative Medicine
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
11 Apr 24
Other Events
6:10am
for Regenerative Medicine (CIRM CLIN2-0989), and another grant from the ALS Association and I AM ALS. BrainStorm completed under an investigational
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Apr 24
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
6:05am
the California Institute for Regenerative Medicine (CIRM CLIN2-0989), and another grant from the ALS Association and I AM ALS. BrainStorm completed under
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
1 Apr 24
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
8:15am
-administration of autologous MSC-NTF cells and was supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989), and another
8-K
EX-99.1
fxv6o22sxlmz
20 Dec 23
BrainStorm Issues 2023 Letter to Shareholders
5:04pm
8-K
EX-99.1
ga9lljqa1rwj4r7ni
22 Nov 23
BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
6:03am
8-K
EX-99.1
3lsmw6yt
14 Nov 23
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
d95iohep5o5qy
24 Oct 23
BrainStorm Cell Therapeutics Announces Strategic Realignment
7:30am
8-K
EX-99.1
eucafnha08
14 Aug 23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:21am
8-K
EX-99.1
v0hmb0rys0fxh8649
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
8-K
EX-99.1
d3jdo e85h
20 Jun 23
BrainStorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair
5:01pm
8-K
EX-99.1
apr0170bff
6 Jun 23
Regulation FD Disclosure
8:58am
8-K
EX-99.1
2n4oh98uhnuf5uh 8dpo
15 May 23
BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
7:15am
8-K
EX-99.1
2m8tex8e9c b2u5
30 Mar 23
BrainStorm Cell Therapeutics Announces Full Year 2022 Financial Results and Provides a Corporate Update
7:18am